Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
| Actual shortage: | 218 (6%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 335 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
62 (26%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PREGABALIN | 300MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-08-22 | 216735 |
| APO-PREGABALIN | 50MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-11-14 | 216738 |
| APO-PREGABALIN | 75MG | CAPSULE | Actual shortage | 2024-01-19 | 2024-07-18 | 216741 |
| APO-PREGABALIN | 300MG | CAPSULE | Resolved | 2020-10-21 | 2020-11-28 | 126771 |
| APO-PREGABALIN | 50MG | CAPSULE | Resolved | 2022-04-08 | 2022-05-13 | 158367 |
| APO-PREGABALIN | 225MG | CAPSULE | Resolved | 2021-04-16 | 2021-04-26 | 137595 |
| APO-PREGABALIN | 50MG | CAPSULE | Resolved | 2021-06-11 | 2021-06-28 | 140782 |
| APO-PREGABALIN | 150MG | CAPSULE | Resolved | 2019-05-08 | 2019-06-17 | 83527 |
| APO-PREGABALIN | 150MG | CAPSULE | Resolved | 2019-07-12 | 2019-11-05 | 89164 |
| APO-PREGABALIN | 150MG | CAPSULE | Resolved | 2017-09-27 | 2017-10-30 | 23623 |
| APO-PREGABALIN | 25MG | CAPSULE | Resolved | 2017-09-27 | 2018-01-19 | 23626 |
| APO-PREGABALIN | 50MG | CAPSULE | Resolved | 2017-09-27 | 2018-01-19 | 23629 |
| APO-PREGABALIN | 25MG | CAPSULE | Resolved | 2023-09-01 | 2023-10-20 | 203560 |
| APO-PROCAINAMIDE CAP 250MG | 250MG | CAPSULE | Actual shortage | 2017-08-13 | 2017-10-05 | 18976 |
| APO-PROCAINAMIDE CAP 375MG | 375G | CAPSULE | Actual shortage | 2017-08-13 | 2017-10-05 | 18979 |
| APO-PROCAINAMIDE CAP 500MG | 500MG | CAPSULE | Actual shortage | 2017-08-13 | 2017-10-05 | 18982 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2017-09-04 | 2017-10-27 | 20885 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2020-05-08 | 2020-06-08 | 114318 |
| APO-PROPAFENONE | 300MG | TABLET | Resolved | 2017-03-11 | 2018-08-30 | 460 |
| APO-PROPAFENONE | 150MG | TABLET | Resolved | 2017-05-04 | 2017-07-13 | 8880 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 3MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110956 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |